TNF and systemic lupus erythematosus: Our findings reveal that EA treatment inhibited IFN‐γ and TNF‐α production by CD8+ T cells in the uterus of pregnant lupus mice and improved the placental damage in lupus mice, thereby revealing the putative therapeutic benefit of EA in pSLE disease.